Obeticholic Acid: Unlocking Liver Health with FXR Agonism
Explore the therapeutic potential of obeticholic acid, a key FXR agonist for liver disease management.
Get a Quote & SampleProduct Core Value
Obeticholic Acid
Obeticholic acid stands as a significant advancement in the treatment of liver diseases, particularly primary biliary cholangitis (PBC). As a potent and selective agonist of the farnesoid X receptor (FXR), it plays a crucial role in regulating bile acid, cholesterol, and lipid metabolism within the liver and intestines. Its mechanism of action directly addresses the underlying pathologies of several liver conditions, offering a new avenue for therapeutic intervention.
- Discover the intricacies of obeticholic acid for primary biliary cholangitis, a key indication for this pharmaceutical raw material.
- Understand the FXR agonist mechanism of action in liver health, highlighting how this compound influences metabolic pathways.
- Learn about the obeticholic acid NASH treatment potential, exploring its role in managing non-alcoholic steatohepatitis.
- Investigate the bile acid metabolism regulation by obeticholic acid, a vital aspect of its therapeutic efficacy in liver disease.
Advantages Offered
Targeted FXR Activation
Obeticholic acid selectively activates the Farnesoid X Receptor (FXR), a critical regulator of bile and cholesterol metabolism. This targeted approach helps manage liver conditions by influencing key metabolic pathways.
Therapeutic for PBC
Its efficacy in treating primary biliary cholangitis makes it a valuable pharmaceutical intermediate, offering a treatment option for patients who cannot tolerate other therapies.
Potential in NASH and Beyond
Ongoing research into the obeticholic acid NASH treatment potential suggests broader applications in addressing complex liver ailments, including portal hypertension.
Key Applications
Pharmaceutical Raw Material
Sourced as a high-purity API, obeticholic acid serves as a fundamental building block for advanced pharmaceutical formulations targeting liver diseases.
Primary Biliary Cholangitis (PBC) Treatment
As a leading indication, obeticholic acid is instrumental in managing PBC, offering a crucial therapeutic option for affected patients.
Nonalcoholic Steatohepatitis (NASH) Research
The promising obeticholic acid NASH treatment potential drives ongoing research into its application for this growing liver condition.
Bile Acid Homeostasis Regulation
By modulating bile acid metabolism, obeticholic acid contributes to restoring balance in liver function, which is essential for overall hepatic health.